Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.

"Declarations GuarantorThe scientific guarantor of this publication is Bachir Taouli, MD, MHA. Conflict of interestThe authors of this manuscript declare relationships with the following companies:Bachir Taouli: research support: Bayer, Takeda, Regeneron, Siemens, Echosens, Helio Genomics; Consultant: Bayer, Guerbet, Ascelia.Ahmed Ba-Ssalamah: Consultant: Bayer; Honorarium for lectures: Bayer.Julius Chapiro: Consultant: AstraZeneca, Bayer, Guerbet, Philips; Research grants: Guerbet, Philips.Jagpreet Chhatwal: Consultant: Bayer; Partner: Value Analytics Labs.Kathryn Fowler: Consultant: Bayer, GE; Grant support: GE, Median, Pfizer.Tae Wook Kang: Consultant: Bayer.Gesine Knobloch: Employee: Bayer AG, Radiology, PharmaceuticalsDow-Mu Koh: Consultant: Bayer.Masatoshi Kudo: Consultant: Bayer; Lectures/honoraria: Bayer, Chugai, Eisai, Eli Lilly, Takeda; Grants: AbbVie, Chugai, EA Pharma, Eisai, GE Healthcare, Gilead Sciences, Otsuka, Sumitomo Dainippon Pharma, Taiho, Takeda.Jeong Min Lee: Grants: Bayer, Bracco, Canon Healthcare, Central Medical Service, GE Healthcare, Guerbet, Philips Healthcare, Samsung Medison; Personal fees: Bayer Healthcare, Guerbet, Philips, Samsung Medison, Siemens Healthineers.Takamichi Murakami: Consultant: Bayer; Grants: Siemens, GE, Canon.David J. Pinato: Lecture fees: Bayer, Bristol Myers Squibb, EISAI, Falk Foundation, Roche, ViiV Healthcare; Travel expenses: Bayer, Bristol Myers Squibb; Consultant: AstraZeneca, Avammune, Bayer, DaVolterra, EISAI, Exact Sciences, H3B, Mina Therapeutics, Mursla, Roche; Research funding (to institution): Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme. David J. Pinato is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416), the Foundation for Liver Research, and from the Associazione Italiana per la Ricerca sul Cancro (AIRC MFAG Grant ID 25697) and acknowledges support by the NIHR Imperial Biomedical Research Centre (BRC), the Imperial Experimental Cancer Medicine Centre (ECMC), and the Imperial College Tissue Bank.Kristina I. Ringe: Consultant: Bayer, Imactis.Bin Song: Consultant: Bayer.Parissa Tabrizian: Consultant, Honoraria: Bayer, AstraZeneca, Boston Scientific.Jin Wang: Consultant: Bayer.Jeong Hee Yoon: Consultant: Bayer; Honoraria: Bayer, Philips Healthcare.Mengsu Zeng: Consultant: Bayer.Jian Zhou: Consultant: Bayer.Valérie Vilgrain: Lectures: Canon Medical, GE Healthcare, Guerbet, Roche, Sirtex, Supersonic Imagine; Advisory board: Guerbet; Consultant: Bayer; Expert testimony: Bayer, Guerbet, Sirtex, Quantum Surgical (to institution). Statistics and biometryNo complex statistical methods were necessary for this paper. Informed consentWritten informed consent was not required for this study because it is a review paper. Ethical approvalInstitutional Review Board approval was not required because this is a review paper. Study subjects or cohorts overlapNot applicable as this is a review paper. MethodologyNot applicable as this is a review paper Conflict of interest The authors of this manuscript declare relationships with the following companies: Bachir Taouli: research support: Bayer, Takeda, Regeneron, Siemens, Echosens, Helio Genomics; Consultant: Bayer, Guerbet, Ascelia. Ahmed Ba-Ssalamah: Consultant: Bayer; Honorarium for lectures: Bayer. Julius Chapiro: Consultant: AstraZeneca, Bayer, Guerbet, Philips; Research grants: Guerbet, Philips. Jagpreet Chhatwal: Consultant: Bayer; Partner: Value Analytics Labs. Kathryn Fowler: Consultant: Bayer, GE; Grant support: GE, Median, Pfizer. Tae Wook Kang: Consultant: Bayer. Gesine Knobloch: Employee: Bayer AG, Radiology, Pharmaceuticals Dow-Mu Koh: Consultant: Bayer. Masatoshi Kudo: Consultant: Bayer; Lectures/honoraria: Bayer, Chugai, Eisai, Eli Lilly, Takeda; Grants: AbbVie, Chugai, EA Pharma, Eisai, GE Healthcare, Gilead Sciences, Otsuka, Sumitomo Dainippon Pharma, Taiho, Takeda. Jeong Min Lee: Grants: Bayer, Bracco, Canon Healthcare, Central Medical Service, GE Healthcare, Guerbet, Philips Healthcare, Samsung Medison; Personal fees: Bayer Healthcare, Guerbet, Philips, Samsung Medison, Siemens Healthineers. Takamichi Murakami: Consultant: Bayer; Grants: Siemens, GE, Canon. David J. Pinato: Lecture fees: Bayer, Bristol Myers Squibb, EISAI, Falk Foundation, Roche, ViiV Healthcare; Travel expenses: Bayer, Bristol Myers Squibb; Consultant: AstraZeneca, Avammune, Bayer, DaVolterra, EISAI, Exact Sciences, H3B, Mina Therapeutics, Mursla, Roche; Research funding (to institution): Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme. David J. Pinato is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416), the Foundation for Liver Research, and from the Associazione Italiana per la Ricerca sul Cancro (AIRC MFAG Grant ID 25697) and acknowledges support by the NIHR Imperial Biomedical Research Centre (BRC), the Imperial Experimental Cancer Medicine Centre (ECMC), and the Imperial College Tissue Bank. Kristina I. Ringe: Consultant: Bayer, Imactis. Bin Song: Consultant: Bayer. Parissa Tabrizian: Consultant, Honoraria: Bayer, AstraZeneca, Boston Scientific. Jin Wang: Consultant: Bayer. Jeong Hee Yoon: Consultant: Bayer; Honoraria: Bayer, Philips Healthcare. Mengsu Zeng: Consultant: Bayer. Jian Zhou: Consultant: Bayer. Valérie Vilgrain: Lectures: Canon Medical, GE Healthcare, Guerbet, Roche, Sirtex, Supersonic Imagine; Advisory board: Guerbet; Consultant: Bayer; Expert testimony: Bayer, Guerbet, Sirtex, Quantum Surgical (to institution)."

"Funding The Global Liver Forum received funding from Bayer."